A Phase II, Randomized, Double-blind, Placebo Controlled Study of Tocilizumab in Patients With Giant Cell Arteritis
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Therapeutic Use
- 16 Nov 2016 Results presented at the 80th American College of Rheumatology and the 51st Annual Meeting of the Association of Rheumatology and Health Professionals
- 07 Mar 2016 Results published in the Lancet.
- 23 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.